Trials / Conditions / Myasthenia Gravis, Ocular
Myasthenia Gravis, Ocular
6 registered clinical trials studyying Myasthenia Gravis, Ocular — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) NCT07249632 | RemeGen Co., Ltd. | Phase 3 |
| Active Not Recruiting | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis NCT06558279 | argenx | Phase 3 |
| Recruiting | Predictors and Prognostic Factors of Myasthenia Gravis Outcome NCT05214612 | Assiut University | — |
| Completed | Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population NCT05380128 | Beijing Tongren Hospital | — |
| Completed | OVEMP in Myasthenia NCT03049956 | University of Zurich | N/A |
| Recruiting | Myasthenia Gravis Foundation of America Global MG Patient Registry NCT06617741 | Myasthenia Gravis Foundation of America | — |